2922.41.00 | | Amino-acids, other than those containing more than one kind of oxygen function, and their esters; salts thereof: | | | | |
2922.41.00 | | Lysine and its esters; salts thereof | | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
2922.41.00 | 10 | Meeting requirements of Food Chemical Codex, Codex Alimentarius or United States Pharmacopeia | kg | | | |
2922.42 | | Glutamic acid and its salts: | | | | |
2922.43 | | Anthranilic acid and its salts: | | | | |
2922.43.10 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 50% |
2922.44.00 | 00 | Tilidine (INN) and its salts | kg | Free | | 15.4¢/kg + 45% |
2922.49.30 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 50% |
2922.50.11 | 00 | Salts of d(-)-p-Hydroxyphenylglycine (¢/- α-Amino-4-hydroxybenzeneacetic acid) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2¢/kg + 3.1% (SG) | 15.4¢/kg + 50% |
2922.50.17 | 00 | Dermatological agents and local anesthetics | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¢/kg + 51.5% |
2922.50.35 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 50% |
2923 | | Quaternary ammonium salts and hydroxides; lecithins and other phosphoaminolipids, whether or not chemically defined: | | | | |
2923.10.00 | 00 | Choline and its salts | kg | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
2923.20.10 | 00 | Purified egg phospholipids, pharmaceutical grade meeting requirements of the U.S. Food and Drug Administration, for use in intravenous fat emulsion | kg | Free | | 16.5¢/kg + 30% |
2924.11.00 | 00 | Acyclic amides (including acyclic carbamates) and their derivatives; salts thereof: | | | | |
2924.21 | | Cyclic amides (including cyclic carbamates) and their derivatives; salts thereof: | | | | |
2924.21 | | Ureines and their derivatives; salts thereof: | | | | |
2924.21.20 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 58% |
2924.23.10 | 00 | 2-Acetamidobenzoic acid (N-acetylanthranilic acid) and its salts: | | | | |
2924.23.70 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 58% |
2924.29.23 | 00 | 4-Aminoacetanilide; 2,2'-Oxamidobis[ethyl-3-(3,5-di-tert-butyl- 4-hydroxyphenyl)propionate]; Acetoacetsulfanilic acid, potassium salt; and N-(2,3-Dihydroxypropyl)-5-N-(2,3-dihydroxy- propyl)acetamido-N'-(2-hydroxyethyl)- 2,4,6-triiodoisophthalamide | kg | Free | | 15.4¢/kg + 58% |
2924.29.71 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 58% |
2925 | | Carboxyimide-function compounds (including saccharin and its salts) and imine-function compounds: | | | | |
2925.11.00 | 00 | Imides and their derivatives; salts thereof: | | | | |
2925.11.00 | 00 | Saccharin and its salts | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4¢/kg + 61% |